|
Competence API Production
|
|
|
|
|
- Our expert team has more than 15 years experience in
process development, production, QC, QA, and regulatory affairs of
biotechnology-derived
APIs (active pharmaceutical ingredients).
- Our management team was formerly responsible at big pharmaceutical companies for
registration of over 20 APIs for clinical studies, product-transfers (various locations and partners) and market supply.
- Our competence covers novel biopharmaceutical
and biogeneric
APIs from clinical material to market supply. Examples of previous projects are listed below.
|
|
|
Product/API
|
Countries
|
Stages of Product
|
|
EPO
|
World-wide
|
Market supply
|
|
various
MABs
|
World-wide
|
Market
supply
|
|
various
PABs
|
EU
|
Market supply
|
|
PA
|
World-wide
|
Market supply
|
|
G-CSF
|
EU
|
Clinical
phase
|
|
Interferons
|
World-wide
|
Market supply
|
|
Adenosine Deaminase
|
US
|
Market supply
|
|
Insulin
|
World-wide
|
Clinical
phase
|
|
Parathormon
|
World-wide
|
Clinical
phase
|
|
|
Abbreviations:
|
|
EPO
|
Erythropoietin
|
|
PA
|
Plasminogen
activator
|
|
G-CSF
|
Granulocyte
colony
stimulating
factor
|
|
PAB
|
Polyclonal
antibody
|
|
MAB
|
Monoclonal
antibody
|
|
|
|
|
|
|
|